Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Abstract 


Background

Despite evidence that eHealth approaches can be effective in reducing HIV risk, their implementation requirements for public health scale up are not well established, and effective strategies to bring these programs into practice are still unknown. Keep It Up! (KIU!) is an online program proven to reduce HIV risk among young men who have sex with men (YMSM) and ideal candidate to develop and evaluate novel strategies for implementing eHealth HIV prevention programs. KIU! 3.0 is a Type III Hybrid Effectiveness-Implementation cluster randomized trial designed to 1) compare two strategies for implementing KIU!: community-based organizations (CBO) versus centralized direct-to-consumer (DTC) recruitment; 2) examine the effect of strategies and determinants on variability in implementation success; and 3) develop materials for sustainment of KIU! after the trial concludes. In this article, we describe the approaches used to achieve these aims.

Methods

Using county-level population estimates of YMSM, 66 counties were selected and randomized 2:1 to the CBO and DTC approaches. The RE-AIM model was used to drive outcome measurements, which were collected from CBO staff, YMSM, and technology providers. Mixed-methods research mapped onto the domains of the Consolidated Framework for Implementation Research will examine determinants and their relationship with implementation outcomes.

Discussion

In comparing our implementation recruitment models, we are examining two strategies which have shown effectiveness in delivering health technology interventions in the past, yet little is known about their comparative advantages and disadvantages in implementation. The results of the trial will further the understanding of eHealth prevention intervention implementation.

Free full text 


Logo of nihpaLink to Publisher's site
Contemp Clin Trials. Author manuscript; available in PMC 2024 Apr 1.
Published in final edited form as:
PMCID: PMC10249332
NIHMSID: NIHMS1881150
PMID: 36842763

Keep it up! 3.0: Study protocol for a type III hybrid implementation-effectiveness cluster-randomized trial

Brian Mustanski, PhD,a,b,c Rana Saber, MS, MSL, PMP,a,b Justin Patrick Jones, MPH, MPP, MA,a,b Kathryn Macapagal, PhD,a,b,c Nanette Benbow, MAS,c Dennis H. Li, PhD, MPH,a,c C. Hendricks Brown, PhD,c Patrick Janulis, PhD,a,b Justin D. Smith, PhD,d Elizabeth Marsh, MS, MA,e Bruce R. Schackman, PhD,f Benjamin P. Linas, MD, MPH,e Krystal Madkins, MPH,a,b Gregory Swann, MS, MA,a,b Abigael Dean, MA,a,b Emily Bettin, BA,a,b and Alexandra Savinkina, MSPHe

Associated Data

Supplementary Materials
Data Availability Statement

Abstract

Background:

Despite evidence that eHealth approaches can be effective in reducing HIV risk, their implementation requirements for public health scale up are not well established, and effective strategies to bring these programs into practice are still unknown. Keep It Up! (KIU!) is an online program proven to reduce HIV risk among young men who have sex with men (YMSM) and ideal candidate to develop and evaluate novel strategies for implementing eHealth HIV prevention programs. KIU! 3.0 is a Type III Hybrid Effectiveness-Implementation cluster randomized trial designed to 1) compare two strategies for implementing KIU!: community-based organizations (CBO) versus centralized direct-to-consumer (DTC) recruitment; 2) examine the effect of strategies and determinants on variability in implementation success; and 3) develop materials for sustainment of KIU! after the trial concludes. In this article, we describe the approaches used to achieve these aims.

Methods:

Using county-level population estimates of YMSM, 66 counties were selected and randomized 2:1 to the CBO and DTC approaches. The RE-AIM model was used to drive outcome measurements, which were collected from CBO staff, YMSM, and technology providers. Mixed-methods research mapped onto the domains of the Consolidated Framework for Implementation Research will examine determinants and their relationship with implementation outcomes.

Discussion:

In comparing our implementation recruitment models, we are examining two strategies which have shown effectiveness in delivering health technology interventions in the past, yet little is known about their comparative advantages and disadvantages in implementation. The results of the trial will further the understanding of eHealth prevention intervention implementation.

Keywords: HIV prevention, eHealth, Cluster randomized trial, Study protocol, Type III hybrid implementation-effectiveness, Implementation science

1. Introduction

Young men who have sex with men (YMSM) account for nearly 70% of all new HIV diagnoses among adolescents and young adults in the United States, and are the only group showing increasing incidence [1]. Despite this increased HIV risk, few interventions in the Centers for Disease Control and Prevention (CDC) Compendium of Evidence-Based Interventions and Best Practices for HIV Prevention Programs [2] are focused on YMSM [3]. The current arsenal of behavioral evidence-based interventions primarily includes face-to-face individual and small-group programs [2], and their reach has been limited by economic and structural barriers to implementation [4]. eHealth approaches may represent a new cost-effective critical modality for engaging YMSM as funding shifts away from health education and behavioral risk reduction to medical approaches [5], and deliver critical intervention content while overcoming barriers to access (e.g., geography [6, 7]), structural issues like stigma in health settings [8], and delivery challenges (e.g., fidelity [9]).

Despite emerging evidence that eHealth approaches can be highly effective in reducing HIV risk or improving care engagement [10, 11], implementation requirements for scale up – namely the cost-effective means to reach a large real-world audience – are not well established. To date, little to no implementation science studies have examined strategies to effectively scale up eHealth HIV prevention programs, an important component of the CDC Ending the HIV Epidemic initiative [12]. To that end, Keep It Up! (KIU!), a CDC designated best-evidence HIV prevention intervention made with and for YMSM, is an ideal candidate to develop and evaluate novel strategies for the implementation of eHealth HIV prevention programs.

KIU! was previously studied in several contexts. A pilot trial (KIU! 1.0) among 102 YMSM, ages 18–24, found a significant decrease in condomless anal sex (CAS) compared to a knowledge-based control [13]. A service-based implementation (KIU! 1.5) at a Chicago community-based organization (CBO) showed significant pre—post reductions in condom errors, total number of male sex partners, and CAS among 579 YMSM, ages 15–24 [14]. A multi-city randomized clinical trial (KIU! 2.0) with 901 YMSM, ages 18–29, demonstrated a significant 40% decrease in sexually transmitted infection (STI) incidence as well as a significant decrease in self-reported CAS [15, 16]. Intervention acceptability was high across all three studies, and KIU! was designated a CDC best-evidence HIV prevention intervention [17].

In this manuscript, we describe the design of the KIU! 3.0 trial, a Type III Hybrid Effectiveness-Implementation cluster randomized trial [18], which aims to 1) compare two implementation strategies, CBO versus direct-to-consumer (DTC) delivered approaches, using a cluster-randomized trial and 2) examine the effect of strategies and determinants on variability in implementation outcomes using a mixed-methods research approach [19, 20] on the domains from the Consolidated Framework for Implementation Research, version 2.0 [21]. The KIU! 3.0 trial will also explore sustainment of KIU! at the completion of the study.

2. Methods

The KIU! 3.0 trial launched in October 2019 but experienced slow participant recruitment and poor retention due, largely, to the COVID-19 pandemic. For example, many HIV testing clinic sites temporarily closed for in person testing or slowed down HIV testing to accommodate COVID-related services. To address these issues and improve recruitment and retention, several changes were made to the KIU! study design “post-launch” in March 2021. The following sections describe the initial design as well as the modifications implemented. At the time of writing, retention for the trial was ongoing.

All procedures involving human participants were in accordance with the ethical standards of Northwestern University Institutional Review Board and with the 1964 Helsinki declaration and its later amendments. All participants provided informed consent.

2.1. Sample frame – County selection and randomization

CBO and DTC delivery are widely used health programming implementation strategies [22, 23] however their relative advantages and disadvantages are unknown. Our sample size target was 66 counties to be randomized 2:1 to the CBO and DTC strategies, respectively, to account for the assumption that there would be counties where no CBOs applied to the request for applications (i.e., there were 44 counties from which 22 CBOs were recruited). We selected US counties with an estimated number of YMSM ≥1,500 [24], which yielded an initial sample frame of 113 counties. An iterative process was developed to narrow the sample frame to 66 counties, which included eliminating counties in which KIU! was previously studied and eliminating nearly all bordering counties to reduce clustering that could produce unintentional exposure across county lines. For more information, see supplementary material entitled County Selection Iterative Process.

2.2. Community-based organization eligibility and recruitment

To select CBO recruitment sites, we published a request for proposals modeled on those created by the CDC and other HIV prevention funders. An objective scoring rubric was developed, and reviewers were trained to score applications on nine criteria. Each application was scored by three review panelists. Once panelists submitted scores, we averaged each application’s scores and selected the highest scoring applicants for funding. For more details on the request for proposals process, see supplementary material entitled Request for Proposals Process.

2.3. Direct to consumer recruitment catchment area

It became evident that certain constraints of our research study design, which was intended to facilitate statistical comparisons of KIU! effectiveness and implementation across arms at the county level, were at odds with running a pragmatic implementation trial. Specifically, nearly a quarter of people interested in joining the DTC arm screened ineligible due to county of residence. As such, post-launch, we expanded the DTC catchment area from 22 counties to nationwide to improve study enrollment and make DTC delivery more pragmatic – in other words, aligned with how other self-guided digital health interventions or applications are often delivered outside research settings (e.g., available to all through the App Store or accessible online).

2.4. Participant inclusion criteria and recruitment

The study has two components: a service component (intervention content) and a research component (surveys and STI testing). All participants were allowed to take part in the service component of the study but had to meet eligibility criteria to complete the research component. YMSM were eligible for participation in the research component if they met the following criteria: 1) tested HIV-negative at the time of registration, 2) reported they were assigned male at birth, 3) identified their current gender identity as male or non-binary, 4) were between the ages of 18–29 at registration, 5) reported CAS with a male partner in the previous six months, and 6) were not on pre-exposure prophylaxis (PrEP), had been on PrEP for less than six months, or reported missing a PrEP dose in the previous six months. Post-launch, participant inclusion criteria were expanded and it was no longer necessary for participants to 1) have received a negative HIV test at registration in order to create additional enrollment channels (e.g., at community events where testing was not occurring on site), or 2) report CAS with a male partner in the previous six months because COVID disrupted patterns of sexual behavior [25]. In addition, the upper age limit of eligibility was increased from 29 to 34 years given older men’s interest in KIU.

Participants were recruited using different strategies based on the arm of the study (CBO versus DTC strategy). For the CBO arm, recruitment was primarily integrated into routine HIV testing and prevention services. Using this approach, after a negative test result, CBO staff explained KIU! And registered interested YMSM, who automatically received a confirmation email that allowed them to set a password and access the KIU! Welcome page. Participants were prompted to complete a baseline survey embedded within the welcome page, where their eligibility for the research component of KIU! Was verified. All participants, regardless of eligibility, could access intervention content upon completing the baseline survey as KIU! Was being delivered as a service while also being studied.

In the DTC arm, participants were recruited primarily through social media, dating apps, and supplemental approaches (e.g., referrals and print ads). Participants registered for KIU! Using a brief online form. Participants who indicated they lived in a county assigned to the CBO arm were marked as ineligible and not provided access to the intervention. All other participants received a confirmation email to set a password and access the KIU! Welcome page where they completed a baseline survey to assess eligibility for the research component. If eligibility requirements were met, participants were sent an at-home HIV test kit and materials to self-administer testing for urethral and rectal gonorrhea and chlamydia. Individuals ineligible for the research study were still offered access to the online intervention content. For additional details on the DTC-mediated recruitment, screening, and testing strategies, see the supplementary material entitled Direct-to-Consumer Recruitment.

2.5. Intervention delivery

For this trial, KIU! was redesigned using multi-tenant architecture into a customizeable mobile, tablet, and desktop responsive web-based participant-facing application and online administrative dashboard. KIU! consisted of four user roles with separate login pages and varying levels of access to the KIU! application: Superusers, Organization Implementers (i.e., Project Directors and Project Coordinators), Organization Recruiters, and YMSM participants. Superusers were comprised exclusively of Northwestern University project staff who oversaw the application’s functionality, content, and data. CBO Project Directors had the ability to register participants, add coordinator and recruiter user roles, and had access to participant data relevant for intervention retention for their CBO (such as participant contact information and contact logs, intervention progress and application usage, etc.); coordinators had similar access as project directors but were limited to only adding and removing recruiter admin roles to KIU!; recruiters were only able to register participants and did not have access to any other application data. DTC project staff had the same level of access as CBO Project Directors. Post-launch, a to-do list feature was created within the adminstrative dashboard for Project Directors and Coordinators to streamline and improve participant retention. The to-do list indicated which participants needed follow-up at different stages of intervention progress.

After registration into the application (either automatically from the DTC online screener or manually by CBO staff), automatic confirmation emails were sent to YMSM participants directing them to set a password and log into the KIU! application to complete a baseline survey hosted in REDCap [26]. After baseline survey completion, YMSM participants were directed to the KIU! homepage consisting of the KIU! content, a technical support page, resources pages, a page of custom-made tools, and page to review their favorited content. YMSM participants were required to complete KIU! content in sequence, although they were able to return to previously viewed material using back buttons, a learning map, the tools page and the favorites pages.

As previously published, we iteratively developed the KIU! intervention with input from YMSM and CBOs [27]. Initially, KIU! was comprised of seven modules completed across three sessions with mandatory 8-h breaks between sessions. Additional content and follow-up surveys were provided in two booster sessions 3 and 6 months after the main intervention. Participants also completed a final follow-up survey and STI testing 12-months post-intervention. Table 1 provides an overview of subject matter covered within each module of the intervention as well as the structured breaks between modules. Post-launch, the 8-h timed breaks between the three main intervention sessions were made optional in response to CBO and YMSM feedback that moving through the sessions without breaks is more consistent with the current media landscape. The time between the main intervention content and the booster sessions was reduced from 3 months (Booster 1) and 6 months (Booster 2) to 6 and 12 weeks, respectively, to allow more time for enrollment due to COVID-related slow-downs while staying within the project budget. Follow-up surveys were removed from Booster 1 and only collected during Booster 2 (12-weeks post-intervention). STI testing data was also only collected at 12-weeks post-intervention. For more details on intervention delivery, including data collected by the application and the experience of YMSM, see the supplementary material entitled KIU! Intervention Delivery.

Table 1.

Overview of subject matter covered within each module of the KIU! intervention.

SessionModuleMain Content
1 In Your CommunityCandid interviews with young gay and bisexual men about their communities, family, sex, and relationships that situate these relationships as important aspects of health. Similar interviews on various topics appear throughout the program.
Hooking Up OnlineThree comic book vignettes about meeting men online for sex that focus on identifying factors that may lead to increased HIV risk, such as mood and substance use, as well as preparatory strategies to reduce those risks.
With FriendsThe first chapter of a scripted soap opera that highlights the risks of making assumptions around HIV status and monogamy and promotes positive norms around getting regular HIV testing and utilizing prevention strategies. Remaining chapters appear throughout subsequent modules.

8-h break (later removed)

2 In Bars and ClubsAn interactive game that addresses the consequences of excessive alcohol consumption and drug use, as well as decisional balance around condom use.
On DatesAn animated story that explores how power dynamics in a dating relationship can affect sexual risk taking. Interactive risk calculators that demonstrate differing levels of HIV and STI risk based on various sexual behaviors.

8-h break (later removed)

3 In RelationshipsAn interactive animated story and supporting videos that model using good communication skills in relationships to help meet one’s sexual, emotional, and health needs.
In the FutureA goal-setting activity that helps participants identify ways to meet their sexual, emotional, and health needs and troubleshoot obstacles to achieving those goals.

3-month break (later changed to 6-week break)

4 Knowing Your StatusNew videos and activities that focus on the importance of regular HIV testing in combination with prevention strategies like condoms and PrEP while adding additional layers of nuance, such as sexual pleasure and preventing condom use errors. There is also a check-in on participants’ goals.

3-month break (later changed to 6-week break)

5 In LoveIn addition to checking in on participants’ goals, new videos demonstrate when and how to discuss stopping condom use with a partner in a long-term relationship, as well as how to restart condoms after stopping.

2.6. Implementation strategies - Community-based organization – Training

Northwestern project staff developed and disseminated online training to CBO implementers. Training modules were developed using the KIU! platform, to offer seamless integration of KIU! content, and covered topics ranging from how to use the KIU! administrative dashboard to recruitment strategies. Ongoing technical assistance and training was provided to CBOs to meet emergent needs of the trial. See the supplementary material entitled Training for more details.

2.7. Implementation strategies – Incentives

Offering financial incentives to encourage participation in HIV prevention and care service programs is a common and pragmatic practice [28] replicated in this intervention. Initially, participants were entered into raffles for $200 gift cards when they completed research surveys at baseline, 3-, 6-, and 12-months post-intervention. In the CBO arm, each organization offered incentives at their own discretion for completion of the baseline survey and service components of the program. Across all CBOs, incentives for baseline survey completion ranged from $5 to $30, with many CBOs choosing not to incentivize baseline completion. For the first three sessions, CBOs offered participants between $10 and $50 total. For completing the two booster content sessions post-intervention, CBOs offered participants between $15 and $75 total. CBOs mostly offered gift card incentives, however, several included non-monetary incentives such as free STI testing and bottles of lube.

After a study protocol modification in July 2020, DTC participants received a $10 or $25 virtual Visa gift card for completing the first three intervention sessions. Incentive amount was randomized by county to determine if a threshold amount must be met for incentives to be effective. DTC participants also received a discount code for an online store that sells adult toys and products. For completing the two boosters, participants were entered into an e-raffle for prizes donated by various vendors. These strategies were based on those successfully used by CBO partners in previous KIU! service implementations to keep YMSMs engaged [14].

The incentive structure was updated twice more due to retention difficulties and youth advisory board feedback that guaranteed payment comparable to other HIV prevention services they participated in would increase retention. Incentives were increased in Spring 2021 with DTC participants receiving a $50 Amazon gift code for completing the first three sessions of the intervention, $10 Amazon gift code for completing 6-week booster content, and $15 Amazon gift code for completing 12-week booster content. Participants in both arms of the study also received a $10 Amazon gift code or virtual Visa gift card for completing 12-week STI testing. The second update in August 2022 increased 12-week incentives for participants in both arms to receive $20 for completing the survey and $20 for completing STI testing.

2.8. Measures

The RE-AIM framework [29, 30] broadly guided our outcome measurement. The main comparison between the CBO and DTC implementation approaches used quantitative data on Reach and Effectiveness. Reach to YMSM was defined as the absolute number of participants enrolled (i.e., completed baseline and screened eligible), as this metric was both comparable across arms and provided the necessary demographic data to examine differences between arms. Measures for calculating effectiveness at reducing HIV risk among engaged YMSM [29, 31, 32] are depicted in Table 2. Mixed-methods assessments for examining the effect of strategies and determinants on implementation variability [33] as well as for measuring sustainability are depicted in Table 3, and constructs related to delivery cost [34, 35] are depicted in Table 4.

Table 2.

Measures of intervention effectiveness.

OutcomeConstructMeasureMeasurement Schedule
Original designAmended design

Baseline3-month6-month12-monthBaseline12-week
Primary HIV Risk BehaviorNumber of condomless male assigned at birth (MAAB) sex partnersXXXXXX
Number of casual condomless MAAB sex partnersXXXXXX
Behavior associated with most recent sexual encounter: condoms, PrEP, substance useXXXXXX
STI IncidenceUrethral and rectal Chlamydia and Gonorrhea - Aptima Combo 2 Assay on the Panther systemXXXX
Secondary: Prevention Continuum HIV/STI TestingAssessing past 3-month HIV and STI testing historyXXXXXX
PrEP Use & AdherenceCurrent & past 3-month PrEP use; adherenceXXXXXX
Secondary: Substance Use Alcohol ProblemsAUDIT Alcohol Consumption Questions (AUDIT-C); Alcohol Use Disorders Identification Test (AUDIT) branched to those scoring >3XXXXXX
Other Drug UsePast 3-month use of marijuana and illicit drugsXXXXXX

Table 3.

Measures of CBO implementation success.

LevelConstructMeasureMeasurement Schedule
Baseline (YMSM)/Pre-Launch (CBO)3-month (YMSM)/4-month (CBO)6-month12-month24-month
Participant a Self-EfficacyConfidence in HIV testing, condom use, and ability to get on PrEPXXXX
Resource AccessAccess to HIV testing, HIV prevention services, and other sexual health servicesXXX
StigmaSexual healthcare avoidance due to LGBTQ stigmaX
SatisfactionSatisfaction with DTC or CBO staff and servicesXXX
Technology Center b EngagementMean number of KIU! modules completed by participantsXXXX
System analytics; Metrics of activity within modulesXXXX
CBO DemographicsX
Training Effectiveness and SatisfactionEffectiveness and satisfaction with trainingXX
Normalization Process TheoryNoMAD: Normalization ProcessXXXX
Organizational Readiness for ChangeOCRBS: Organizational Change Recipient Beliefs ScaleX
Leadership EngagementILS: Implementation Leadership ScaleXXXX
Implementation ClimateICS: Implementation Climate ScaleXXX
Readiness for eHealthReadiness for eHealthX
SustainabilityProgram Sustainability Assessment ToolXX
AdaptationItems based on the FRAME measureXX
CFIR domainsAdministrative DataXXXXX
Qualitative InterviewsXX
a.After the post-launch amendments went into effect, all YMSM participant measures (except stigma) were collected at baseline and 12-week
b.After the post-launch amendments went into effect, all technology center measures continued to be collected at all time points (baseline, 6-week, 12-week)

Table 4.

Measures of cost.

Cost TypeConstructMeasuresSourceMeasurement Schedule
Start-Up RecruitmentStaff time, consultant, and other costsStaff activity logs; study records and CBO interviews/surveysMonthly for start-up period; one-time
Initial trainingNumber and duration of trainingsStudy recordsOne-time
Technology developmentStaff time, content development costsStaff activity logsMonthly for start-up period; one-time
Variable Shipping and processing HIV and STI test kitsNumber of units shipped, STI lab cost per test, staff time per shipmentStudy records; staff interviewsOngoing; one-time
Participant contactsNumber of participant contacts, staff time per contactParticipant contact logs; staff interviewsOngoing; one-time
Time-Dependent Social media advertisementTotal spendingStudy recordsOngoing
Booster training and technical assistanceStaff time by armCBO and DTC participant tracking logs; staff activity logsOngoing; monthly
Other staff activitiesStaff time by armStaff activity logs; CBO interviews/surveysMonthly; one-time
Space and occupancy costsSquare feetStaff interviewsOne-time

2.9. Data analysis – Public health impact

Our primary outcomes were public health impact, defined as reach X effectiveness [29, 31, 32], and cost per infection averted [36, 37]. For this trial, public health impact will be assessed by 1) number of YMSM community reached weighted by their HIV risk, and 2) effectiveness at reducing HIV risk [29, 31, 32]. By measuring individual-level change on these modifiable factors, our index of public health impact allowed for heterogeneity in response to KIU! across individuals, race and age groups, counties, and implementation conditions. Effectiveness was measured by the estimated change in that person’s risk for HIV from baseline to follow-up surveys and as determined by observed changes in target risk factors (such as CAS, STIs, and adherent PrEP use, all of which have major impacts on HIV transmission in YMSM) [3840]. We based our modeling of HIV risk on published single-exposure probabilities and account for multiple exposures using binomial modeling [41]. Because these are individual-based measures, we will use two-level mixed-effect modeling [42].

We followed established guidelines for collecting cost data and conducting economic evaluations. Cost analyses were conducted for each arm from the perspective of the healthcare sector [34, 35]. We followed a micro-costing approach, a technique in which all inputs consumed in an intervention are identified and quantified in detail and then converted into fiscal terms to produce a cost estimate. Cost analysis was used to compute cost per infection averted, which is analogous to the measure used by CDC to decide which effective HIV prevention intervention would be supported as part of a high impact prevention plan [36, 37].

2.10. Data analysis – Compare CBO and DTC implementation strategies

Analyses involve Multivariable Generalized Linear Mixed Models, as they account for nested individual observations within counties and are commonly used in cluster-randomized trials [35, 43]. The multivariable aspect of the model allows for the control of factors that are unbalanced between arms, either because they were not accounted for in the randomization process or because they may have become unbalanced due to loss to follow-up. To account for potential selection bias in constructing an efficient (one degree of freedom) adjustment for measured differences in county-level covariates, we will adjust for the linear combination forming the first canonical covariate that maximally distinguished the sites in the two arms [44, 45]. Similar to propensity score analysis, we will also formally include the model that predicts selection effects [46]. We will estimate standard errors using nonparametric bootstrapping techniques within the multivariable framework treating arm as a dichotomous indicator [35]. The differences between the intervention arms will be evaluated by examining the statistical significance of the level-2 (i.e., cluster level) dichotomous indicator for the intervention arms. We will estimate and compare the difference in predicted mean cost per participant between the arms and will also use those estimates of mean cost to characterize the cost per HIV infection averted in each arm of the study.

For cost-effectiveness analysis, parameters obtained from bootstrapping will be used to estimate cost-effectiveness acceptability curves which will indicate the probability that either intervention implementation strategy is a good value for different willingness-to-pay thresholds (i.e., incremental cost per infection avoided) [47]. Finally, all outcomes analysis will conform to best practices in analysis of randomized trials, including intention-to-treat analysis and sensitivity analysis of missing data. Multilevel multiple imputation models will be used to examine the potential effect of missing responses on the results [4850].

3. Discussion

Cluster-randomized trials are increasingly used in public health and medicine [51], but with a few important exceptions [5255], they have not seen significant application in HIV implementation science. Our trial compares the implementation of two competing implementation strategies – CBO versus DTC. The CBO model, with CBOs directly funded by the CDC or their local health department [56], is the current backbone of implementing HIV prevention programs. The DTC model introduces a novel method of mitigating barriers to regular HIV/STI testing by facilitating self-testing [23], which has been demonstrated to be accurate, acceptable, and feasible, especially among those who may not otherwise seek an HIV test [57]. While both the CBO and DTC arms are two viable implementation strategies, their relative advantages and disadvantages are unknown. By evaluating both strategies head-to-head in this cluster-randomized trial, we will be able to discern their overall effectiveness and identify key moderating factors [33, 58] that could help boost and shape future dissemination and implementation of eHealth HIV prevention interventions [59] and contribute to greater scalability, reach, and public health impact.

This paper described the proposed trial protocol and the post-launch amendments made to the protocol to combat extenuating real-life circumstances that contributed to recruitment and retention challenges in the CBO and DTC arms. The COVID-19 pandemic may have negatively impacted KIU! recruitment and retention through numerous mechanisms: 1) disrupting CBOs’ ability to provide onsite services and recruit individuals; 2) causing a decrease in sexual activity and overall HIV/STI risk and prioritization of sexual health; 3) creating other physical and mental health issues that became higher priorities than HIV prevention (e.g., sudden joblessness, fear of COVID, changing personal and professional responsibilities); and 4) YMSM experiencing “screen fatigue,” as many interactions moved into the virtual space. To address these issues and improve recruitment and retention, several changes were made to the KIU! study design (see Table 5).

Table 5.

Changes to study components after the launch of the trial.

ComponentOriginal DesignAmended Design
Eligibility
 Age18 – 2918 – 34
 HIV statusHIV negative test resultHIV negative test result OR self-report HIV negative or unknown status
 Condomless anal sexSelf-report in previous 6 monthsNo requirement
 Location (DTC arm)22 US countiesNationwide
Delivery
 Session Breaks
 (Sessions 1 – 3)
8-h breaksOptional breaks
 Follow-up Content Timepoint3- and 6-months6- and 12-weeks
 Follow-up Survey Timepoint3-, 6-, and 12-months12-weeks
 Follow-up Testing Timepoint12-months12-weeks
Incentives
 CBO$200 survey raffle; At CBO discretion (sessions 1 – 3 and at 6-weeks)Original design incentives plus $20 (12-week survey) and $20 (12-week at-home STI testing)
 DTC$200 survey raffleOriginal design incentives plus $50 (sessions 1 – 3); $10 (6-week); $20 (12-week survey); $20 (12-week STI testing)

First, study effectiveness was de-emphasized post-launch. Effectiveness was already demonstrated in KIU! 2.0 and based on emerging data, changes in sexual risk may be attributable to COVID effects. Disentangling COVID effects from the effects of the KIU! program would be challenging, if not impossible. This change allowed the DTC arm to recruit nationally, which more closely approximates a pragmatic DTC implementation strategy. Second, the 8-h timed breaks between the three main intervention sessions were removed, and the time between the main intervention content and the booster sessions were reduced from 3 months (Booster 1) and 6 months (Booster 2) to 6 and 12 weeks, respectively. This change was made for the following reasons: 1) previous CBO-based implementations of the intervention were delivered successfully without timed breaks, 2) long-term maintenance of intervention effects were previously shown in KIU! 2.0, 3) requests by CBOs currently enrolled in the KIU! 3.0 trial and 4) this change will not affect implementation aims.

Third, participant inclusion criteria were expanded. KIU! was originally designed to be delivered following a negative HIV test result to utilize testing as a means of recruiting diverse YMSM and leverage YMSM’s attitudes during that teachable moment. However, that specific theoretical mechanism has never been empirically tested to demonstrate that it is a core component of the intervention effect. In fact, in KIU! 1.5, the program was decoupled from testing, and pre—post intervention results remained similar to the KIU! 1.0 pilot effects. Furthermore, not requiring an HIV test allowed CBOs to adopt additional marketing and engagement strategies appropriate to the COVID pandemic. Thus, the requirement of a negative HIV test result before intervention access was removed. Due to the marginal cost of delivery and interest in KIU! from YMSM who had not recently engaged in CAS, this criterion was also removed, as it will not affect study implementation aims, and the COVID-19 pandemic may have reduced CAS. Lastly, the age of eligibility was increased from 29 to 34 since the CDC estimates that the highest-risk YMSM are up to age 34. Again, due to the marginal cost of delivery and interest in KIU! from older YMSM, this criterion was relaxed as it will not affect study implementation aims.

Effective implementation has been described as the greatest challenge to HIV prevention [60, 61] yet there has been insufficient research testing implementation strategies that will ensure effective interventions get to the right individuals at the right time in the right dose [4]. While prior implementation science studies have compared capacity-building approaches for individual and small-group prevention programs [6265], there have been little-to-none on eHealth HIV prevention [22, 6668]. The comparison of two viable strategies in this trial will be a contribution to the eHealth literature as well as the implementation science literature that rarely tests markedly different delivery strategies against one another in the same trial. This design led to limitations in what could be reasonably compared between arms and could pose challenges in determining which strategy would be preferred as results could indicate specific strengths and weaknesses for each strategy. Thus, not a clear “winner” as is often sought in head-to-head trials such as this. The use of incentives is another limitation because it may introduce bias into the trial. However, we will do empirical tests to assess if incentives matter, the amount necessary to affect intervention completion, and for which participants incentives encourage intervention completion. The proposed study will lead the way to understanding the implementation of eHealth HIV prevention interventions to ensure that the promise of cost-effective scalability is realized [69].

Supplementary Material

Request for Proposals Process

Direct to Consumer Recruitment

Training Documents

KIU Intervention Delivery

County Selection Iterative Process

Acknowledgments

Research reported in this publication was supported by the National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), and Office of the Director (OD) of the National Institutes of Health under Award Number R01 MH118213. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We would like to thank the staff at the 22 CBOs at which KIU! is being implemented as well as the many community partners who are assisting in recruitment for the DTC arm. Additionally, we thank the following centers and institutions for their immeasurable contributions to our trial: Center for Prevention Implementation Methodology for Drug Abuse and HIV; Prevention Science and Methodology Group; Third Coast Center for AIDS Research; Research Application Design and Development, Institute for Sexual and Gender Minority Health and Wellbeing; the Institute for Sexual and Gender Minority Health and Wellbeing, Feinberg School of Medicine, and the Department of Medical Social Sciences at Northwestern University; Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV (CHERISH); Department of Population Health Sciences at Weill Cornell Medicine; Boston Medical Center; and Erik Munson of Clinical Laboratory Science at Marquette University.

Funding

This work is supported by the National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), and Office of the Director (OD) of the National Institutes of Health [R01MH118213].

Abbreviations:

CBOcommunity based organization
CAScondomless anal sex
CDCCenters for Disease Control and Prevention
DTCdirect-to-consumer
KIU!Keep It Up!
PrEPpre-exposure prophylaxis
STIsexually transmitted infection
YMSMyoung men who have sex with men

Footnotes

CRediT authorship contribution statement

Brian Mustanski: Methodology, Writing – Review & Editing; Rana Saber: Software, Writing – Original Draft, Writing – Review & Editing; Justin Patrick Jones: Writing – Original Draft, Writing – Review & Editing; Kathryn Macapagal: Methodology, Writing – Original Draft; Nanette Benbow: Methodology, Writing – Review & Editing; Dennis H. Li: Methodology, Writing – Original Draft; C. Hendricks Brown: Methodology; Patrick Janulis: Methodology; Justin D. Smith: Methodology; Elizabeth Marsh: Methodology; Bruce R. Schackman: Methodology; Benjamin P. Linas: Methodology; Krystal Madkins: Writing – Original Draft, Writing – Review & Editing; Gregory Swann: Methodology, Writing – Original Draft; Abigael Dean: Writing – Original Draft; Emily Bettin: Methodology, Writing – Original Draft; Alexandra Savinkina: Writing – Original Draft

Trial Registration: NCT03896776, clinicaltrials.gov, 1 April 2019

Ethics approval and consent to participate

This protocol was approved by the IRB at Northwestern University, IRB reference number STU00207476. YMSM and CBO staff participants were informed of the aims of the study as well as data protection; all participants were consented to participate in our trial. Reports derived from our trial will be delivered in aggregate such that participants cannot be identified.

Consent for publication

Not applicable.

Declaration of Competing Interest

The authors declare that they have no competing interests.

Availability of Data and Materials

The datasets generated and/or analyzed during this trial will be available from the investigators upon reasonable request.

References

[1] Centers for Disease Control and Prevention, HIV Surveillance Report, 2018 (Updated), 2020.
[2] Centers for Disease Control and Prevention, Complete listing of risk reduction evidence-based behavioral interventions, Available from: http://www.cdc.gov/hiv/prevention/research/compendium/rr/complete.html,2022.
[3] Mustanski B, Fisher CB, HIV rates are increasing in gay/bisexual teens: IRB barriers to research must be resolved to bend the curve, Am. J. Prev. Med 51 (2)(2016) 249–252, 10.1016/j.amepre.2016.02.026. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[4] Fagan AA, Bumbarger BK, Barth RP, Bradshaw CP, Cooper BR, Supplee LH, et al., Scaling up evidence-based interventions in US public systems to prevent behavioral health problems: challenges and opportunities, Prev. Sci 20 (8) (2019) 1147–1168, 10.1007/s11121-019-01048-8. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[5] Centers for Disease Control and Prevention, CDC’s HIV prevention priorities, Available from: https://www.cdc.gov/hiv/policies/strategic-priorities/mobilizing/prevention-priorities.html, 2023.
[6] Lenhart A, Teen, Social Media and Technology Overview 2015, Pew Research Center, 2015.
[7] Grov C, Westmoreland DA, Carneiro PB, Stief M, MacCrate C, Mirzayi C, et al., Recruiting vulnerable populations to participate in HIV prevention research: findings from the together 5000 cohort study, Ann. Epidemiol 35 (2019) 4–11, 10.1016/j.annepidem.2019.05.003. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[8] Casey LS, Reisner SL, Findling MG, Blendon RJ, Benson JM, Sayde JM, et al., Discrimination in the United States: experiences of lesbian, gay, bisexual, transgender, and queer Americans, Health Serv. Res. 54 Suppl 2 (Suppl. 2) (2019) 1454–1466, 10.1111/1475-6773.13229. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[9] Li DH, Brown CH, Gallo C, Morgan E, Sullivan PS, Young SD, et al., Design considerations for implementing eHealth behavioral interventions for HIV prevention in evolving sociotechnical landscapes, Curr. HIV/AIDS Rep 16 (4) (2019) 335–348, 10.1007/s11904-019-00455-4. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[10] Nguyen LH, Tran BX, Rocha LEC, Nguyen HLT, Yang C, Latkin CA, et al., A systematic review of eHealth interventions addressing HIV/STI prevention among men who have sex with men, AIDS Behav. 23 (9) (2019) 2253–2272, 10.1007/s10461-019-02626-1. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[11] Henny KD, Wilkes AL, McDonald CM, Denson DJ, Neumann MS, A rapid review of eHealth interventions addressing the continuum of HIV care (2007–2017), AIDS Behav. 22 (1) (2018) 43–63, 10.1007/s10461-017-1923-2. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[12] Centers for Disease Control and Prevention, Ending the HIV epidemic in the U.S. (EHE), Available from: https://www.cdc.gov/endhiv/index.html, 2023.
[13] Mustanski B, Garofalo R, Monahan C, Gratzer B, Andrews R, Feasibility, acceptability, and preliminary efficacy of an online HIV prevention program for diverse young men who have sex with men: the keep it up! intervention, AIDS Behav. 17 (9) (2013) 2999–3012, 10.1007/s10461-013-0507-z. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[14] Greene GJ, Madkins K, Andrews K, Dispenza J, Mustanski B, Implementation and evaluation of the keep it up! online HIV prevention intervention in a community-based setting, AIDS Educ. Prev 28 (3) (2016) 231–245, 10.1521/aeap.2016.28.3.231. [Abstract] [CrossRef] [Google Scholar]
[15] Mustanski B, Madkins K, Greene GJ, Parsons JT, Johnson BA, Sullivan P, et al., Internet-based HIV prevention with at-home sexually transmitted infection testing for young men having sex with men: study protocol of a randomized controlled trial of keep it up! 2.0, JMIR Res. Prot 6 (1) (2017), e1, 10.2196/resprot.5740. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[16] Mustanski B, Parsons JT, Sullivan PS, Madkins K, Rosenberg E, Swann G, Biomedical and behavioral outcomes of keep it up!: an eHealth HIV prevention program RCT, Am. J. Prev. Med 55 (2) (2018) 151–158, 10.1016/j.amepre.2018.04.026. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[17] Centers for Disease Control and Prevention, Compendium of evidence-based interventions and best practices for HIV prevention, Available from: https://www.cdc.gov/hiv/research/interventionresearch/compendium/index.html, 2022.
[18] Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C, Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact, Med. Care 50 (3) (2012) 217–226, 10.1097/MLR.0b013e3182408812. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[19] Aarons GA, Fettes DL, Sommerfeld DH, Palinkas LA, Mixed methods for implementation research: application to evidence-based practice implementation and staff turnover in community-based organizations providing child welfare services, Child. Maltreat 17 (1) (2012) 67–79, 10.1177/1077559511426908. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[20] Palinkas LA, Cooper B. Roades, Mixed methods evaluation in dissemination and implementation science, in: Brownson RC, Colditz GA, Proctor EK (Eds.), Dissemination and Implementation Research in Health, 2nd ed., Oxford University Press, New York, NY, 2017. [Google Scholar]
[21] Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J, The updated consolidated framework for implementation research based on user feedback, Implement. Sci 17 (1) (2022) 75, 10.1186/s13012-022-01245-0. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[22] Bailey J, Mann S, Wayal S, Hunter R, Free C, Abraham C, et al., Sexual health promotion for young people delivered via digital media: a scoping review, Public Health Research 3 (13) (2015), 10.3310/phr03130. [Abstract] [CrossRef] [Google Scholar]
[23] Campbell CK, Lippman SA, Moss N, Lightfoot M, Strategies to increase HIV testing among MSM: a synthesis of the literature, AIDS Behav. 22 (8) (2018) 2387–2412, 10.1007/s10461-018-2083-8. [Abstract] [CrossRef] [Google Scholar]
[24] Grey JA, Bernstein KT, Sullivan PS, Purcell DW, Chesson HW, Gift TL, et al., Estimating the population sizes of men who have sex with men in US states and counties using data from the American community survey, JMIR Public Health Surveill. 2 (1) (2016), e14, 10.2196/publichealth.5365. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[25] Pampati S, Emrick K, Siegler AJ, Jones J, Changes in sexual behavior, PrEP adherence, and access to sexual health services because of the COVID-19 pandemic among a cohort of PrEP-using MSM in the south, J. Acq. Imm. Def 87 (1) (2021) 639–643, 10.1097/Qai.0000000000002640. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[26] Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG, Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support, J. Biomed. Inform 42 (2) (2009) 377–381, 10.1016/j.jbi.2008.08.010. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[27] Mustanski B, Lyons T, Garcia SC, Internet use and sexual health of young men who have sex with men: a mixed-methods study, Arch. Sex. Behav 40 (2) (2011) 289–300, 10.1007/s10508-009-9596-1. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[28] Bassett IV, Wilson D, Taaffe J, Freedberg KA, Financial incentives to improve progression through the HIV treatment cascade, Curr. Opin. HIV AIDS 10 (6)(2015) 451–463, 10.1097/Coh.0000000000000196. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[29] Glasgow RE, Vogt TM, Boles SM, Evaluating the public health impact of health promotion interventions: the RE-AIM framework, Am. J. Public Health 89 (9) (1999) 1322–1327. [Abstract] [Google Scholar]
[30] Kessler RS, Purcell EP, Glasgow RE, Klesges LM, Benkeser RM, Peek CJ, What does it mean to “employ” the RE-AIM model? Eval. Health Prof 36 (1)(2013) 44–66, 10.1177/0163278712446066. [Abstract] [CrossRef] [Google Scholar]
[31] Abrams DB, Orleans CT, Niaura RS, Goldstein MG, Prochaska JO, Velicer W, Integrating individual and public health perspectives for treatment of tobacco dependence under managed health care: a combined stepped-care and matching model, Ann. Behav. Med 18 (4) (1996) 290–304, 10.1007/BF02895291. [Abstract] [CrossRef] [Google Scholar]
[32] Glasgow RE, Klesges LM, Dzewaltowski DA, Estabrooks PA, Vogt TM, Evaluating the impact of health promotion programs: using the RE-AIM framework to form summary measures for decision making involving complex issues, Health Educ. Res 21 (5) (2006) 688–694, 10.1093/her/cyl081. [Abstract] [CrossRef] [Google Scholar]
[33] Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC, Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science, Implement. Sci 4 (2009) 50, 10.1186/1748-5908-4-50. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[34] Drummond MF, Schulpher MJ, Claxton K, Stoddart GL, Torrance GW, Methods for the Economic Evaluation of Health Care Programmes, 4th ed., Oxford University Press, 2015. [Google Scholar]
[35] Glick HA, Doshi JA, Sonnad SS, Polsky D, Economic Evaluation in Clinical Trials, Oxford University Press, 2014. [Google Scholar]
[36] Centers for Disease Control and Prevention Division of HIV/AIDS Prevention, Turning the Tide on HIV: Division of HIV/AIDS Prevention Annual Report 2013, Centers for Disease Control and Prevention, Atlanta, GA, 2013. [Google Scholar]
[37] Purcell D, CDC’s approach to high-impact HIV prevention in the era of expanding prevention options, in: 23rd Annual Illinois State HIV/STD Conference; Springfield, IL, 2014. [Google Scholar]
[38] Chou R, Evans C, Hoverman A, Sun C, Dana T, Bougatsos C, et al., Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US preventive services task force, JAMA. 321 (22) (2019) 2214–2230, 10.1001/jama.2019.2591. [Abstract] [CrossRef] [Google Scholar]
[39] Hughes JP, Baeten JM, Lingappa JR, Magaret AS, Wald A, de Bruyn G, et al., Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples, J. Infect. Dis 205 (3) (2012) 358–365, 10.1093/infdis/jir747. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[40] Smith DK, Herbst JH, Zhang X, Rose CE, Condom effectiveness for HIV prevention by consistency of use among men who have sex with men in the United States, J. Acquir. Immune Defic. Syndr 68 (3) (2015) 337–344, 10.1097/QAI.0000000000000461. [Abstract] [CrossRef] [Google Scholar]
[41] Goodreau SM, Rosenberg ES, Jenness SM, Luisi N, Stansfield SE, Millett GA, et al., Sources of racial disparities in HIV prevalence in men who have sex with men in Atlanta, GA, USA: a modelling study, Lancet HIV 4 (7) (2017) E311–E320, 10.1016/S2352-3018(17)30067-X. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[42] Hedeker D, Gibbons RD, Flay BR, Random-effects regression models for clustered data with an example from smoking prevention research, J. Consult. Clin. Psychol 62 (4) (1994) 757–765. [Abstract] [Google Scholar]
[43] Fiero MH, Huang S, Oren E, Bell ML, Statistical analysis and handling of missing data in cluster randomized trials: a systematic review, Trials. 17 (1)(2016). [Europe PMC free article] [Abstract] [Google Scholar]
[44] Brown CH, Liao J, Principles for designing randomized preventive trials in mental health: an emerging developmental epidemiology paradigm, Am. J. Community Psychol 27 (5) (1999) 673–710, 10.1023/A:1022142021441. [Abstract] [CrossRef] [Google Scholar]
[45] Ten Have TR, Normand SL, Marcus SM, Brown CH, Lavori P, Duan N, Intent-to-treat vs. non-intent-to-treat analyses under treatment non-adherence in mental health randomized trials, Psychiatr. Ann 38 (12) (2008) 772–783, 10.3928/00485713-20081201-10. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[46] Brown CH, Wang W, Kellam SG, Muthen BO, Petras H, Toyinbo P, et al., Methods for testing theory and evaluating impact in randomized field trials: intent-to-treat analyses for integrating the perspectives of person, place, and time, Drug Alcohol Depend. 95 (Suppl. 1) (2008) S74–S104, 10.1016/j.drugalcdep.2007.11.013. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[47] Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG, Cost-Effectiveness in Health and Medicine, 2nd ed., Oxford University Press, New York, NY, 2017. [Google Scholar]
[48] Graham JW, Missing data analysis: making it work in the real world, Annu. Rev. Psychol 60 (2009) 549–576, 10.1146/annurev.psych.58.110405.085530. [Abstract] [CrossRef] [Google Scholar]
[49] Hollis S, Campbell F, What is meant by intention to treat analysis? Survey of published randomised controlled trials, BMJ. 319 (7211) (1999) 670–674, 10.1136/bmj.319.7211.670. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[50] White IR, Horton NJ, Carpenter J, Pocock SJ, Strategy for intention to treat analysis in randomised trials with missing outcome data, BMJ. 342 (2011), d40, 10.1136/bmj.d40. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[51] National Institutes of Health, Research Methods Resource: Group- or Cluster-Randomized Trials (GRTs), National Institutes of Health, Bethesda, MD, 2017. Available from: https://researchmethodsresources.nih.gov/grt.aspx. [Google Scholar]
[52] Vermund SH, Fidler SJ, Ayles H, Beyers N, Hayes RJ, Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia, J. Acquir. Immune Defic. Syndr 63 (Suppl. 2) (2013) S221–7, 10.1097/QAI.0b013e318299c3f4. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[53] Coates TJ, Kulich M, Celentano DD, Zelaya CE, Chariyalertsak S, Chingono A, et al., Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH project accept; HPTN 043): a cluster-randomised trial, Lancet Glob. Health 2 (5) (2014) e267–e277, 10.1016/S2214-109X(14)70032-4. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[54] Glassman JR, Potter SC, Baumler ER, Coyle KK, Estimates of intraclass correlation coefficients from longitudinal group-randomized trials of adolescent HIV/STI/pregnancy prevention programs, Health Educ. Behav 42 (4) (2015) 545–553, 10.1177/1090198114568308. [Abstract] [CrossRef] [Google Scholar]
[55] Witte SS, Wu E, El-Bassel N, Hunt T, Gilbert L, Medina KP, et al., Implementation of a couple-based HIV prevention program: a cluster randomized trial comparing manual versus web-based approaches, Implement. Sci 9 (2014) 116, 10.1186/s13012-014-0116-x. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[56] National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Disease, and Tuberculosis Prevention, Comprehensive high-impact HIV prevention projects for community-based organizations: CDC-RFA-PS15–1502, Centers for Disease Control and Prevention, Atlanta, GA, 2014. [Google Scholar]
[57] Johnson MC, Chung R, Leung SYJ, Edelstein Z, Yuan YC, Flavin SM, Combating stigma through HIV self-testing: New York State’s HIV home test giveaway program for sexual minorities, J. Public Health Man 28 (2) (2022) 174–183, 10.1097/Phh.0000000000001138. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[58] Durlak JA, Studying program implementation is not easy but it is essential, Prev. Sci 16 (8) (2015) 1123–1127, 10.1007/s11121-015-0606-3. [Abstract] [CrossRef] [Google Scholar]
[59] Baker TB, Gustafson DH, Shah D, How can research keep up with eHealth? Ten strategies for increasing the timeliness and usefulness of eHealth research, J. Med. Internet Res 16 (2) (2014), e36, 10.2196/jmir.2925. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[60] Ross J, Stevenson F, Lau R, Murray E, Factors that influence the implementation of e-health: a systematic review of systematic reviews (an update), Implement. Sci. 11 (1) (2016) 146, 10.1186/s13012-016-0510-7. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[61] Mustanski B, Smith JD, Keiser B, Li DH, Benbow N, Supporting the growth of domestic HIV implementation research in the United States through coordination, consultation, and collaboration: how we got here and where we are headed, J. Acquir. Immune Defic. Syndr 90 (S1) (2022) S1–S8, 10.1097/QAI.0000000000002959. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[62] Kegeles SM, Rebchook G, Tebbetts S, Arnold E, Team T, Facilitators and barriers to effective scale-up of an evidence-based multilevel HIV prevention intervention, Implement. Sci. 10 (2015) 50, 10.1186/s13012-015-0216-2. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[63] Jia RM, Du JT, Zhao YC, Characteristics of the health information seeking behavior of LGBTQ+ individuals: a systematic review on information types, information sources and influencing factors, J. Doc 78 (2) (2022) 361–388. [Google Scholar]
[64] Hamilton AB, Mittman BS, Campbell D, Hutchinson C, Liu H, Moss NJ, et al., Understanding the impact of external context on community-based implementation of an evidence-based HIV risk reduction intervention, BMC Health Serv. Res 18 (1) (2018) 11, 10.1186/s12913-017-2791-1. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[65] Leeman J, Calancie L, Hartman MA, Escoffery CT, Herrmann AK, Tague LE, et al., What strategies are used to build practitioners’ capacity to implement community-based interventions and are they effective?: a systematic review, Implement. Sci 10 (2015) 80, 10.1186/s13012-015-0272-7. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[66] Muessig KE, Nekkanti M, Bauermeister J, Bull S, Hightow-Weidman LB, A systematic review of recent smartphone, internet and web 2.0 interventions to address the HIV continuum of care, Curr. HIV/AIDS Rep 12 (1) (2015) 173–190, 10.1007/s11904-014-0239-3. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[67] Kemp CG, Velloza J, Implementation of eHealth interventions across the HIV care cascade: a review of recent research, Curr. HIV/AIDS Rep 15 (6) (2018) 403–413, 10.1007/s11904-018-0415-y. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
[68] Guse K, Levine D, Martins S, Lira A, Gaarde J, Westmorland W, et al., Interventions using new digital media to improve adolescent sexual health: a systematic review, J. Adolesc. Health 51 (6) (2012) 535–543, 10.1016/j.jadohealth.2012.03.014. [Abstract] [CrossRef] [Google Scholar]
[69] Bauer MS, Damschroder L, Hagedorn H, Smith J, Kilbourne AM, An introduction to implementation science for the non-specialist, BMC Psychol. 3 (2015) 32, 10.1186/s40359-015-0089-9. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]

Citations & impact 


Impact metrics

Jump to Citations

Alternative metrics

Altmetric item for https://www.altmetric.com/details/142941840
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/142941840

Article citations

Data 


Data behind the article

This data has been text mined from the article, or deposited into data resources.

Similar Articles 


To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.

Funding 


Funders who supported this work.

NIDA NIH HHS (1)

NIMH NIH HHS (1)